FrancophonIA/ELRC3.0 huggingface dataset:
English: The heart rate-corrected QT interval in duloxetine-treated patients did not differ from that seen in placebo-treated patients.
Croatian: Vrijednost QT-intervala korigiranog za srčanu frekvenciju u bolesnika liječenih duloksetinom nije se razlikovala od one viđene u bolesnika koji su primali placebo.
English: Duloxetine Lilly should normally not be used for children and adolescents under 18 years.
Croatian: Duloksetin Lilly se u načelu ne smije primjenjivati u djece i adolescenata mlađih od 18 godina.
English: The pharmacokinetics of duloxetine and its metabolites have not been studied in patients with mild or severe hepatic insufficiency.
Croatian: Farmakokinetika duloksetina i njegovih metabolita nije ispitivana u bolesnika s blagom ni u bolesnika s teškom insuficijencijom jetre.
English: Duloxetine is used under different trademarks in several indications (treatment of diabetic neuropathic pain, major depressive disorder, generalised anxiety disorder and stress urinary incontinence).
Croatian: Duloksetin je prisutan na tržištu pod različitim zaštićenim imenima i primjenjuje se za nekoliko indikacija (liječenje boli kod dijabetičke neuropatije, velikog depresivnog poremećaja, generaliziranog anksioznog poremećaja i stresne urinarne inkontinencije).
English: If you take more Duloxetine Lilly than you should
Croatian: Ako uzmete više lijeka Duloksetin Lilly nego što ste trebali
English: Generalised Anxiety Disorder: Duloxetine Lilly demonstrated statistically significant superiority over placebo in five out of five studies including four randomised, double-blind, placebo-controlled acute studies and a relapse prevention study in adult patients with generalised anxiety disorder.
Croatian: Generalizirani anksiozni poremećaj: Duloksetin Lilly se pokazao statistički značajno superiornijim u odnosu na placebo u pet od pet provedenih ispitivanja, od kojih su četiri bila randomizirana, dvostruko slijepa, placebom kontrolirana kratkoročna ispitivanja, a jedno ispitivanje prevencije relapsa u odraslih bolesnika s generaliziranim anksioznim poremećajem.
English: Capsule content: hypromellose, hypromellose acetate succinate, sucrose, sugar spheres, talc, titanium dioxide (E171), triethyl citrate (See end of section 2 for further information on sucrose).
Croatian: Sadržaj kapsule: hipromeloza, hipromelozaacetatsukcinat, saharoza, šećerne kuglice, talk, titanijev dioksid (E171), trietilcitrat (vidjeti kraj dijela 2 za dodatne informacije o saharozi).
English: Duloxetine is a combined serotonin (5-HT) and noradrenaline (NA) reuptake inhibitor.
Croatian: Mehanizam djelovanja Duloksetin je kombinirani inhibitor ponovne pohrane serotonina (5-HT) i noradrenalina (NA).
English: • chest pain, feeling cold, thirst, shivering, feeling hot, abnormal gait
Croatian: • bol u prsnom košu, osjećaj hladnoće, žeđ, drhtanje, osjećaj vrućine, nenormalan hod
English: In the 12 week acute phase of three clinical trials of duloxetine in patients with diabetic neuropathic pain, small but statistically significant increases in fasting blood glucose were observed in duloxetinetreated patients.
Croatian: U 12-tjednoj akutnoj fazi triju kliničkih ispitivanja duloksetina u bolesnika s bolom kod dijabetičke neuropatije primijećena su mala, ali statistički značajna povećanja koncentracije glukoze u krvi natašte u bolesnika koji su uzimali duloksetin.
English: Also, the long-term safety effects concerning growth, maturation, and cognitive and behavioural development of Duloxetine Lilly in this age group have not yet been demonstrated.
Croatian: dugoročni sigurnosni učinci lijeka Duloksetin Lilly na rast, sazrijevanje te intelektualni razvoj i razvoj ponašanja nisu još dokazani u ovoj dobnoj skupini.
English: Duloxetine Lilly 60 mg is available in packs of 28, 56, 84 and 98 hard gastro-resistant capsules and in multipacks containing 100 (5 packs of 20) and 500 (25 packs of 20) hard gastro-resistant capsules.
Croatian: Duloksetin Lilly 60 mg dostupan je u pakiranjima od 28, 56, 84 i 98 tvrdih želučanootpornih kapsula i u višestrukim pakiranjima koja sadrže 100 (5 kutija s 20) i 500 (25 kutija s 20) tvrdih želučanootpornih kapsula.
English: Duloxetine has been associated with an increase in blood pressure and clinically significant hypertension in some patients.
Croatian: U nekih je bolesnika primjena duloksetina povezana s povišenjem krvnog tlaka i klinički značajnom hipertenzijom.
English: Epidemiological data have suggested that the use of SSRIs in pregnancy, particularly in late pregnancy, may increase the risk of persistent pulmonary hypertension in the newborn (PPHN).
Croatian: (SSRI) u trudnoći, osobito u visokom stupnju trudnoće, može povećati rizik od perzistentne plućne hipertenzije u novorođenčadi (PPHN).
English: In prenatal/postnatal toxicity studies in the rat, duloxetine induced adverse behavioural effects in the offspring at exposures below maximum clinical exposure (AUC).
Croatian: U ispitivanjima prenatalne/postnatalne toksičnosti u štakora duloksetin je izazvao štetne učinke na ponašanje mladunčadi pri izloženosti manjoj od maksimalne kliničke izloženosti (AUC).
English: Caution is advised if Duloxetine Lilly is co-administered with medicinal products that are predominantly metabolised by CYP2D6 (risperidone, tricyclic antidepressants [TCAs] such as nortriptyline, amitriptyline, and imipramine) particularly if they have a narrow therapeutic index (such as flecainide, propafenone and metoprolol).
Croatian: Savjetuje se oprez ako se Duloksetin Lilly primjenjuje istodobno s lijekovima koji se metaboliziraju prvenstveno pomoću CYP2D6 (risperidon, triciklički antidepresivi poput nortriptilina, amitriptilina i imipramina), naročito ako imaju uzak terapijski indeks (poput flekainida, propafenona i metoprolola).
English: Hard gastro-resistant capsule.
Croatian: Tvrda želučanootporna kapsula.
English: Tolerability of Duloxetine Lilly 60 mg once daily in elderly patients was comparable to that seen in the younger adults.
Croatian: Podnošljivost lijeka Duloksetin Lilly u dozi od 60 mg jednom dnevno u starijih bolesnika bila je usporediva s onom koja je uočena u mlađih odraslih osoba.
English: • sudden involuntary jerks or twitches of the muscles, sensation of restlessness or an inability to sit or stand still, feeling nervous, difficulty concentrating, changes in sense of taste, difficulty controlling movement e.g. lack of coordination or involuntary movements of the muscles,
Croatian: • iznenadni nevoljni trzaji ili grčevi mišića, osjećaj nemira ili nemogućnost mirnog sjedenja ili stajanja, nervoza, poteškoće s koncentracijom, promjene osjeta okusa, poteškoće pri kontroliranju pokreta npr. nedostatak koordinacije ili nevoljni pokreti mišića, sindrom nemirnih nogu, loša kvaliteta sna
English: In addition, one patient who transitioned from placebo to duloxetine experienced a suicidal behaviour while taking duloxetine.
Croatian: Osim toga, u jednog bolesnika koji je prešao s placeba na duloksetin se suicidalno ponašanje pojavilo tijekom liječenja duloksetinom.
English: Generally these symptoms are mild to moderate, however, in some patients they may be severe in intensity.
Croatian: U načelu su ti simptomi blagi do umjereni, ali u nekih bolesnika mogu biti i teški.
English: Tel: +372 6 817 280
Croatian: Eesti Tel: +372 6 817 280
English: Duloxetine normalised pain thresholds in several preclinical models of neuropathic and inflammatory pain and attenuated pain behaviour in a model of persistent pain.
Croatian: Farmakodinamički učinci Duloksetin je normalizirao prag boli u nekoliko pretkliničkih modela neuropatske i upalne boli te je umanjio bolno ponašanje u modelu dugotrajne boli.
English: • abnormal vaginal bleeding, abnormal periods, including heavy, painful, irregular or prolonged periods, unusually light or missed periods, pain in the testicles or scrotum
Croatian: • nenormalno vaginalno krvarenje, nenormalne mjesečnice, uključujući obilne, bolne, neredovite ili produljene mjesečnice, neuobičajeno blage mjesečnice ili izostanak mjesečnice, bol u testisima ili mošnji
English: As with other serotonergic agents, serotonin syndrome, a potentially life-threatening condition, may occur with duloxetine treatment, particularly with concomitant use of other serotonergic agents (including SSRIs, SNRIs tricyclic antidepressants or triptans), with agents that impair metabolism of serotonin such as MAOIs, or with antipsychotics or other dopamine antagonists that may affect the serotonergic neurotransmitter systems (see sections 4.3 and 4.5).
Croatian: Kao i kod drugih serotoninergičkih lijekova, kod liječenja duloksetinom može se javiti serotoninski sindrom, stanje koje može biti opasno po život, osobito pri istodobnoj primjeni drugih serotoninergičkih lijekova (uključujući selektivne inhibitore ponovne pohrane serotonina (SSRI), inhibitore ponovne pohrane serotonina i noradrenalina (SNRI), tricikličke antidepresive ili triptane) i lijekova koji utječu na metabolizam serotonina, poput MAOI, ili antipsihotika ili drugih antagonista dopamina koji mogu utjecati na sustave serotoninergičke neurotransmisije (vidjeti dijelove 4.3 i 4.5).
English: Duloxetine Lilly must not be used in patients with severe renal impairment (creatinine clearance <30 ml/min; see section 4.3).
Croatian: Duloksetin Lilly se ne smije primjenjivati u bolesnika s teškim oštećenjem bubrežne funkcije (klirens kreatinina < 30 ml/min; vidjeti dio 4.3).
English: Ear and labyrinth disorders Tinnitus1
Croatian: Poremećaji uha i labirinta tinitus1
English: Extra-pyramidal symptoms6
Croatian: ekstrapiramidni simptomi6
English: Dehydration Hyponatraemia SIADH6
Croatian: dehidracija hiponatrijemija (SIADH)6
English: Compared with healthy subjects, the apparent plasma clearance of duloxetine was 79% lower, the apparent terminal half-life was 2.3 times longer, and the AUC was 3.7 times higher in patients with moderate liver disease.
Croatian: usporedbi sa zdravim ispitanicima, u bolesnika s umjereno teškom bolešću jetre je prividni klirens duloksetina iz plazme bio je 79% manji, prividan poluvijek 2,3 puta dulji, a AUC 3,7 puta veći.
English: Duloxetine Lilly may have a mild to moderate effect on your ability to drive and use machines.
Croatian: Duloksetin Lilly može imati blagi do umjereni učinak na sposobnost upravljanja vozilima i rada sa strojevima.
English: Neither duloxetine (30-120 mg) nor the active control arm (fluoxetine 20-40 mg) statistically separated from placebo on change from baseline to endpoint in the Children´s Depression Rating Scale-Revised (CDRS-R) total score.
Croatian: Ni skupina koja je primala duloksetin (30-120 mg) ni kontrolna skupina koja je primala aktivni lijek (fluoksetin 20-40 mg) nisu se statistički razlikovale od skupine koja je primala placebo u smislu promjene ukupnoga broja bodova na ljestvici depresije u djece (engl.
English: • throat inflammation that causes a hoarse voice
Croatian: • upala grla koja uzrokuje promuklost
English: For patients not experiencing somnolence, clinical response was observed in 47% of patients receiving duloxetine and 27% of patients on placebo.
Croatian: Među bolesnicima koji nisu osjetili somnolenciju klinički odgovor je uočen u 47% bolesnika koji su primali duloksetin te 27% bolesnika koji su primali placebo.
English: Do not take more than the daily amount of Duloxetine Lilly that has been prescribed for you in one day.
Croatian: Nemojte u jednome danu uzeti više od propisane dnevne doze lijeka Duloksetin Lilly.
English: Response and remission rates were also statistically significantly higher with Duloxetine Lilly compared with placebo.
Croatian: Stope odgovora na liječenje i remisije bile su također statistički značajno veće pri uzimanju lijeka Duloksetin Lilly nego pri uzimanju placeba.
English: Read the leaflet before use.
Croatian: Prije uporabe pročitajte uputu o lijeku.
English: Severe renal impairment (creatinine clearance <30 ml/min) (see section 4.4).
Croatian: Teško oštećenje bubrežne funkcije (klirens kreatinina < 30 ml/min) (vidjeti dio 4.4).
English: Duloxetine should be used with caution in patients treated with other medicinal products associated with hepatic injury.
Croatian: Duloksetin se mora primjenjivati s oprezom u bolesnika koji se liječe drugim lijekovima koji mogu uzrokovati oštećenje jetre.
English: Your doctor will tell you if you should be taking Duloxetine Lilly.
Croatian: Liječnik će Vam reći smijete li uzimati Duloksetin Lilly.
English: Generalised anxiety disorder
Croatian: Generalizirani anksiozni poremećaj
English: − are taking other medicines containing duloxetine (see ‘Other medicines and Duloxetine Lilly')
Croatian: − ako uzimate druge lijekove koji sadrže duloksetin (pogledajte „Drugi lijekovi i Duloksetin Lilly“)
English: Liver disease resulting in hepatic impairment (see section 5.2).
Croatian: Bolest jetre čija je posljedica oštećenje jetrene funkcije (vidjeti dio 5.2).
English: Duloxetine Lilly demonstrated statistically significant superiority over placebo as measured by improvement in the Hamilton Anxiety Scale (HAM-A) total score and by the Sheehan Disability Scale (SDS) global functional impairment score.
Croatian: Duloksetin Lilly se pokazao statistički značajno superiornijim u odnosu na placebo, mjereno ukupnim poboljšanjem na Hamiltonovoj ljestvici anksioznosti (HAM-A) i ukupnim funkcijskim oštećenjem prema Sheenanovoj ljestvici onesposobljenosti (engl.
English: The incidence of relapse during the 6-months double-blind follow-up period was 14% for Duloxetine Lilly and 42% for placebo.
Croatian: Incidencija relapsa tijekom 6-mjesečnog razdoblja dvostruko slijepog praćenja iznosila je 14% u bolesnika koji su uzimali Duloksetin Lilly i 42% u onih koji su uzimali placebo.
English: Infections and infestations
Croatian: Infekcije i infestacije laringitis
English: As a general recommendation, caution should be exercised when treating the elderly (see sections 4.2 and 4.4).
Croatian: Općenito se u liječenju starijih osoba nalaže oprez (vidjeti dijelove 4.2 i 4.4).
English: Effects of other medicinal products on duloxetine Antacids and H2 antagonists: Co-administration of duloxetine with aluminium- and magnesiumcontaining antacids or duloxetine with famotidine had no significant effect on the rate or extent of duloxetine absorption after administration of a 40 mg oral dose.
Croatian: Antacidi i antagonisti H2 receptora: Istodobna primjena duloksetina i antacida koji sadrže aluminij ili magnezij ili duloksetina i famotidina nije značajno utjecala na brzinu ni opseg apsorpcije duloksetina nakon peroralne primjene doze od 40 mg.
English: There was also a small increase in fasting blood glucose and in total cholesterol in duloxetine-treated patients while those laboratory tests showed a slight decrease in the routine care group.
Croatian: Vrijednosti glukoze u krvi natašte i ukupnog kolesterola malo su porasle u bolesnika liječenih duloksetinom, dok su iste laboratorijske vrijednosti bile malo snižene u skupini bolesnika na standardnom liječenju.
English: Gastric lavage may be indicated if performed soon after ingestion or in symptomatic patients.
Croatian: Ispiranje želuca može biti indicirano ako se može provesti ubrzo nakon uzimanja lijeka ili u simptomatskih bolesnika.
English: End stage renal disease (ESRD) patients receiving dialysis had 2-fold higher duloxetine Cmax and AUC values compared with healthy subjects.
Croatian: Bolesnici u završnom stadiju bubrežne bolesti, koji su na dijalizi, imali su dvostruko više vrijednosti Cmax i AUC-a duloksetina nego zdravi ispitanici.
English: • dizziness, feeling sluggish, tremor, numbness, including numbness, pricking or tingling of the skin
Croatian: • omaglica, tromost, nevoljno drhtanje, utrnulost, uključujući obamrlost, bockanje ili trnci na koži
English: Symptoms of overdose include sleepiness, coma, serotonin syndrome (a rare reaction which may cause feelings of great happiness, drowsiness, clumsiness, restlessness, feeling of being drunk, fever, sweating or rigid muscles), fits, vomiting and fast heart rate.
Croatian: Simptomi predoziranja uključuju pospanost, komu, serotoninski sindrom (rijetka reakcija koja može izazvati osjećaj velike sreće, omamljenost, nespretnost, nemir, osjećaj poput opijenosti, vrućicu, znojenje ili ukočenost mišića), napadaje, povraćanje i ubrzan rad srca.
English: The efficacy and safety of Duloxetine Lilly 30-120 mg once daily in elderly patients with generalised anxiety disorder was similar to that seen in studies of younger adult patients.
Croatian: Djelotvornost i sigurnost lijeka Duloksetin Lilly u dozi od 30-120 mg jednom dnevno u starijih bolesnika s generaliziranim anksioznim poremećajem bile su slične onima primijećenima u ispitivanjima mlađih odraslih bolesnika.
English: Anaphylactic reaction
Croatian: alergijske reakcije
English: During 52 weeks of placebo-controlled double blind treatment, duloxetine-treated patients with recurrent MDD had a significantly longer symptom free period (p<0.001) compared with patients randomised to placebo.
Croatian: Tijekom 52 tjedna placebom kontroliranog dvostruko slijepog ispitivanja, bolesnici s opetovanim velikim depresivnim poremećajem koji su primali duloksetin imali su značajno dulji period bez simptoma (p<0,001) u usporedbi s bolesnicima koji su primali placebo.
English: 20 hard gastro-resistant capsules.
Croatian: 20 tvrdih želučanootpornih kapsula.
English: In an open label long-term uncontrolled study, the pain reduction in patients responding to 8-weeks of acute treatment of Duloxetine Lilly 60 mg once daily was maintained for a further 6-months as measured by change on the Brief Pain Inventory (BPI) 24-hour average pain item.
Croatian: U otvorenom dugotrajnom nekontroliranom ispitivanju smanjenje boli u bolesnika koji su reagirali na 8-tjedno akutno liječenje lijekom Duloksetin Lilly u dozi od 60 mg jednom dnevno održalo se tijekom sljedećih 6 mjeseci, mjereno promjenom 24-satnih podataka o prosječnoj boli u kratkom upitniku o boli (eng.
English: • increased sweating, (itchy) rash
Croatian: • pojačano znojenje, osip (koji svrbi)
English: It is therefore advised that when duloxetine treatment is no longer required, gradual discontinuation by dose tapering should be carried out (see sections 4.2 and 4.4).
Croatian: Stoga se savjetuje postupan prekid liječenja smanjivanjem doze kada liječenje duloksetinom više nije potrebno (vidjeti dijelove 4.2 i 4.4).
English: Capsule shell: gelatin, sodium lauryl sulfate, titanium dioxide (E171), indigo carmine (E132), yellow iron oxide (E172) (60 mg only) and edible green ink (30 mg) or edible white ink (60 mg).
Croatian: Ovojnica kapsule: želatina, natrijev laurilsulfat, titanijev dioksid (E171), indigo karmin (E132), žuti željezov oksid (E172) (samo u kapsulama od 60 mg) i jestiva zelena tinta (30 mg) ili jestiva bijela tinta (60 mg).
English: The active substance is duloxetine.
Croatian: Djelatna tvar je duloksetin.
English: Medicinal products metabolised by CYP1A2: The pharmacokinetics of theophylline, a CYP1A2 substrate, were not significantly affected by co-administration with duloxetine (60 mg twice daily).
Croatian: Lijekovi koji se metaboliziraju pomoću CYP1A2: Nije bilo znatnijeg utjecaja na farmakokinetiku teofilina, koji je supstrat CYP1A2, prilikom istodobne primjene s duloksetinom (60 mg dva puta dnevno).
English: Cases of suicidal thoughts and suicidal behaviours have been reported during duloxetine therapy or early after treatment discontinuation (see section 4.8).
Croatian: Prijavljeni su slučajevi suicidalnih misli i suicidalnog ponašanja za vrijeme uzimanja duloksetina ili ubrzo nakon prekida uzimanja lijeka (vidjeti dio 4.8).
English: 28 hard gastro-resistant capsules 56 hard gastro-resistant capsules 84 hard gastro-resistant capsules 98 hard gastro-resistant capsules
Croatian: 28 tvrdih želučanootpornih kapsula 56 tvrdih želučanootpornih kapsula 84 tvrde želučanootporne kapsule 98 tvrdih želučanootpornih kapsula
English: The initiation of treatment with Duloxetine Lilly is contraindicated in patients with uncontrolled hypertension that could expose patients to a potential risk of hypertensive crisis (see sections 4.4 and
Croatian: Kontraindicirano je započeti liječenje lijekom Duloksetin Lilly u bolesnika s nekontroliranom hipertenzijom koja bolesnika može izložiti potencijalnom riziku od hipertenzivne krize (vidjeti dijelove 4.4 i 4.8).
English: If you stop taking Duloxetine Lilly
Croatian: Ako prestanete uzimati Duloksetin Lilly
English: Duloxetine Lilly 60 mg to 120 mg once daily demonstrated statistically significant superiority compared to placebo (p<0.001) on the prevention of relapse, as measured by time to relapse.
Croatian: Duloksetin Lilly u dozi od 60 do 120 mg jednom dnevno bio je statistički značajno superiorniji u odnosu na placebo (p<0,001) u prevenciji relapsa, mjereno vremenom do pojave relapsa.
English: Discontinuation symptoms seen with duloxetine may include hypotonia, tremor, jitteriness, feeding difficulty, respiratory distress and seizures.
Croatian: Simptomi ustezanja duloksetina mogu uključivati hipotoniju, tremor, nervozne pokrete, poteškoće s hranjenjem, respiratorni distres i napadaje.
English: Duloxetine Lilly showed comparable efficacy results to venlafaxine in terms of improvements on the HAM-A total score.
Croatian: Rezultati djelotvornosti lijeka Duloksetin Lilly bili su usporedivi s rezultatima venlafaksina u smislu poboljšanja ukupnog rezultata na HAM-A ljestvici.
English: The starting and recommended maintenance dose is 60 mg daily with or without food.
Croatian: Početna doza i preporučena doza održavanja je 60 mg dnevno, s hranom ili bez nje.
English: These symptoms may include floppy muscles, trembling, jitteriness, not feeding properly, trouble with breathing and fits.
Croatian: Ovi simptomi mogu uključivati mlohave mišiće, drhtanje, nervozne pokrete, poteškoće s hranjenjem, poteškoće s disanjem i napadaje.
English: Monoamine oxidase inhibitors (MAOIs): Due to the risk of serotonin syndrome, duloxetine should not be used in combination with non-selective irreversible monoamine oxidase inhibitors (MAOIs), or within at least 14 days of discontinuing treatment with an MAOI.
Croatian: 4.5 Interakcije s drugim lijekovima i drugi oblici interakcija Inhibitori monoaminooksidaze (MAOI): Zbog rizika od serotoninskog sindroma duloksetin se ne smije uzimati u kombinaciji s neselektivnim ireverzibilnim inhibitorima monoaminooksidaze (MAOI) niti najmanje 14 dana nakon prekida liječenja inhibitorima MAO.
English: Pharmacokinetics of duloxetine in paediatric patients aged 7 to 17 years with major depressive disorder following oral administration of 20 to 120 mg once daily dosing regimen was characterized using population modelling analyses based on data from 3 studies.
Croatian: Pedijatrijska populacija Farmakokinetika duloksetina nakon peroralne primjene doze od 20-120 mg jedanput na dan u pedijatrijskih bolesnika u dobi od 7 do 17 godina s velikim depresivnim poremećajem okarakterizirana je uz pomoć analiza populacijskih modela na temelju podataka iz 3 ispitivanja.
English: Mydriasis has been reported in association with duloxetine, therefore, caution should be used when prescribing Duloxetine Lilly to patients with increased intraocular pressure, or those at risk of acute narrow-angle glaucoma.
Croatian: Prijavljeni su slučajevi midrijaze pri uzimanju duloksetina te se stoga Duloksetin Lilly mora s oprezom propisivati bolesnicima s povišenim očnim tlakom i onima s rizikom za pojavu akutnog glaukoma uskog kuta.
English: The 60 mg capsules are blue and green and are printed with ‘60 mg' and the code ‘9542'.
Croatian: Kapsule od 60 mg su plave i zelene boje s otisnutim oznakom „60 mg“ i oznakom „9542“.
English: The same precautions observed when treating patients with major depressive disorder should therefore be observed when treating patients with other psychiatric disorders.
Croatian: Kod liječenja bolesnika s drugim psihijatrijskim poremećajima mora se stoga pridržavati istih mjera opreza kao i kod liječenja bolesnika s velikim depresivnim poremećajem.